Brad Glasscock | PKU Case Study: Use of Surrogate Endpoints

  Рет қаралды 209

EveryLife Foundation for Rare Diseases

EveryLife Foundation for Rare Diseases

6 жыл бұрын

PKU Case Study: Use of Surrogate Endpoints
Brad Glasscock, Group Vice President, Head of Global Regulatory Affairs at
BioMarin Pharmaceutical Inc.

Пікірлер
Ralph Kern, MD, MHSc | ALS Case Study: Clinical Trial Designs for Small Patient Populations
11:28
EveryLife Foundation for Rare Diseases
Рет қаралды 352
PKU patients discuss living with their disorder
2:43
University of Kentucky
Рет қаралды 48 М.
Beat Ronaldo, Win $1,000,000
22:45
MrBeast
Рет қаралды 158 МЛН
Мясо вегана? 🧐 @Whatthefshow
01:01
История одного вокалиста
Рет қаралды 7 МЛН
Mom Hack for Cooking Solo with a Little One! 🍳👶
00:15
5-Minute Crafts HOUSE
Рет қаралды 23 МЛН
Iris Recognition by Prof. John Daugman
53:57
SAIConference
Рет қаралды 29 М.
Dennis Dietzen, Ph.D.
12:18
EveryLife Foundation for Rare Diseases
Рет қаралды 76
Phenylketonuria - causes, symptoms, diagnosis, treatment, pathology
5:34
Osmosis from Elsevier
Рет қаралды 379 М.
The Best Skincare Of 2024
13:28
Dr Dray
Рет қаралды 83 М.
Новый год 2025 на ТНТ "ComedyVision!" @ComedyClubRussia
1:16:27
Malaria | Osmosis Study Video
14:28
Medscape
Рет қаралды 493 М.
Beat Ronaldo, Win $1,000,000
22:45
MrBeast
Рет қаралды 158 МЛН